CMTx Biotech
Joann Wilson is the VP of Chemistry, Manufacturing & Controls at CMTx Biotech. Previously, Joann was Vice President at Exelixis. Joann holds a Ph.D. Chemistry from Wayne State University.
This person is not in any offices
CMTx Biotech
CMTx Biotech is a clinical-stage biopharmaceutical company that is developing an orally administered small molecule for the treatment of sepsis patients at risk of Acute Respiratory Distress Syndrome (ARDS) and/or Multiple Organ Dysfunction Syndrome (MODS), including those infected with SARS-CoV-2 (COVID-19).